Detalles de la búsqueda
1.
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression.
J Clin Psychopharmacol
; 42(4): 408-412, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727083
2.
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Hum Psychopharmacol
; 37(4): e2836, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179810
3.
Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Eur Arch Psychiatry Clin Neurosci
; 271(3): 577-582, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32078034
4.
Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1.
Ann Hepatol
; 19(2): 166-171, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711914
5.
The Portuguese Version of the Immunosuppressant Therapy Adherence Scale (ITAS) among Liver Transplant Recipient Patients: Translation and Psychometric Properties.
Ann Hepatol
; 17(1): 104-109, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29311393
6.
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
Trends Psychiatry Psychother
; 45: e20210298, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904800
7.
Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.
Trends Psychiatry Psychother
; 2023 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37717263
8.
Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.
J Affect Disord
; 330: 7-15, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871913
9.
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review.
Harv Rev Psychiatry
; 30(2): 135-145, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267254
10.
Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review.
Harv Rev Psychiatry
; 29(5): 340-350, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34366408
11.
Psychometric properties the of Brazilian Portuguese version of Snaith-Hamilton Pleasure Scale (SHAPS).
Trends Psychiatry Psychother
; 43(1): 23-29, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33681903
12.
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial.
J Psychiatr Res
; 138: 576-583, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991996
13.
Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study.
Psychiatry Res
; 303: 114058, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34153630
14.
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
J Affect Disord
; 264: 527-534, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786030
15.
MENTAL DISORDERS AND QUALITY OF LIFE IN PATIENTS AWAITING LIVER TRANSPLANTATION.
Arq Gastroenterol
; 56(4): 339-343, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31618394
16.
Quality of life, risk behaviors and depression among carriers of hepatitis C virus and human T-cell lymphotropic virus type 1: a comparative study.
Braz J Infect Dis
; 23(4): 224-230, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31344356
17.
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial
Trends psychiatry psychother. (Impr.)
; 45: e20210298, 2023. tab, graf
Artículo
en Inglés
|
LILACS-Express
| ID: biblio-1424715
18.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
Medicine (Baltimore)
; 97(38): e12414, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30235716
19.
Letter to the editor about "comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression".
J Affect Disord
; 286: 117-119, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33714804
20.
Letter to the editor - Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
J Affect Disord
; 283: 265-266, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33571796